Divis Laboratories has appointed Dr. S. Devendra Rao (DIN: 10481393) as Additional Director designated as �Whole-time Director (Manufacturing)`, for a term of 5 years commencing from 10 February 2024. Powered by Capital Market - Live News

Net profit of Divi`s Laboratories rose 16.99% to Rs 358.00 crore in the quarter ended December 2023 as against Rs 306.00 crore during the previous quarter ended December 2022. Sales rose 8.61% to Rs 1855.00 crore in the quarter ended December 2023 as against Rs 1708.00 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales1855.001708.00 9 OPM %26.3623.95 - PBDT584.00522.00 12 PBT489.00435.00 12 NP358.00306.00 17 Powered by Capital Market - Live News

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 10 February 2024.Powered by Capital Market - Live News

Net profit of Divi`s Laboratories declined 29.41% to Rs 348.00 crore in the quarter ended September 2023 as against Rs 493.00 crore during the previous quarter ended September 2022. Sales rose 2.91% to Rs 1909.00 crore in the quarter ended September 2023 as against Rs 1855.00 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales1909.001855.00 3 OPM %25.0933.48 - PBDT564.00701.00 -20 PBT469.00615.00 -24 NP348.00493.00 -29 Powered by Capital Market - Live News

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 6 November 2023.Powered by Capital Market - Live News